It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Runt-related transcription factor (Runx) family plays various roles in the homeostasis of cartilage. Here, we examined the role of Runx2 and Runx3 for osteoarthritis development in vivo and in vitro. Runx3-knockout mice exhibited accelerated osteoarthritis following surgical induction, accompanied by decreased expression of lubricin and aggrecan. Meanwhile, Runx2 conditional knockout mice showed biphasic phenotypes: heterozygous knockout inhibited osteoarthritis and decreased matrix metallopeptidase 13 (Mmp13) expression, while homozygous knockout of Runx2 accelerated osteoarthritis and reduced type II collagen (Col2a1) expression. Comprehensive transcriptional analyses revealed lubricin and aggrecan as transcriptional target genes of Runx3, and indicated that Runx2 sustained Col2a1 expression through an intron 6 enhancer when Sox9 was decreased. Intra-articular administration of Runx3 adenovirus ameliorated development of surgically induced osteoarthritis. Runx3 protects adult articular cartilage through extracellular matrix protein production under normal conditions, while Runx2 exerts both catabolic and anabolic effects under the inflammatory condition.
Possible distinct contributions of Runx 2 and Runx3 in osteoarthritis have not been clarified. Nagata et al. show that Runx3 protects adult articular cartilage by extracellular matrix protein production in normal conditions, while Runx2 exerts both catabolic and anabolic effects during inflammation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Yano, Fumiko 4 ; Chijimatsu, Ryota 4 ; Omata, Yasunori 5
; Mori, Daisuke 4 ; Makii, Yuma 1 ; Kawata, Manabu 1 ; Kaneko, Taizo 1 ; Iwanaga, Yasuhide 1 ; Nakamoto, Hideki 1 ; Maenohara, Yuji 1 ; Tachibana, Naohiro 1 ; Ishikura, Hisatoshi 1 ; Higuchi, Junya 1 ; Taniguchi, Yuki 1 ; Ohba, Shinsuke 6 ; Chung, Ung-il 7 ; Tanaka, Sakae 1
; Saito, Taku 1
1 The University of Tokyo, Sensory & Motor System Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
2 The University of Tokyo, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
3 The University of Tokyo, Sensory & Motor System Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
4 The University of Tokyo, Bone and Cartilage Regenerative Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
5 The University of Tokyo, Sensory & Motor System Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Bone and Cartilage Regenerative Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
6 The University of Tokyo, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, Bunkyo-ku, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); Nagasaki University, Department of Cell Biology, Institute of Biomedical Sciences, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
7 Nagasaki University, Department of Cell Biology, Institute of Biomedical Sciences, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)




